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Hundreds  of  protein-coding  genes  and  regulatory  non-coding  RNAs  (ncRNAs)  are subject  to  genomic
imprinting.  The  mono-allelic  DNA methylation  marks  that control  imprinted  gene  expression  are  somat-
ically  maintained  throughout  development,  and  this  process  is  linked  to  speciﬁc  chromatin  features.  Yet,
at many  imprinted  genes,  the  mono-allelic  expression  is  lineage  or tissue-speciﬁc.  Recent studies  provide
mechanistic  insights  into  the  developmentally-restricted  action  of  the  ‘imprinting  control  regions’  (ICRs).
At  several  imprinted  domains,  the  ICR  expresses  a  long  ncRNA  that  mediates  chromatin  repression  in  cisenomic imprinting
on-coding RNA
NA methylation
hromatin
(and  probably  in  trans  as  well).  ICRs  at other  imprinted  domains  mediate  higher-order  chromatin  struc-
turation  that  enhances,  or  prevents,  transcription  of close-by  genes.  Here,  we  present  how  chromatin
and  ncRNAs  contribute  to  developmental  control  of  imprinted  gene  expression  and discuss  implications
for  disease.  This  article  is  part  of  a  Directed  Issue  entitled:  Epigenetics  dynamics  in development  and
disease.
© 2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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/).1. Epigenetic control of mammalian genomic imprinting
Epigenetic regulation contributes to development and homeo-
stasis by initiating and maintaining stable patterns of gene
expression (Jaenisch and Bird, 2003). During mammalian develop-
ment, different epigenetic phenomena control transcription levels
by conferring mono-allelic expression of some genes. This includes
the process of X chromosome inactivation in females and genomic
imprinting (Lee and Bartolomei, 2013), a regulatory mechanism
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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hat brings about mono-allelic gene expression depending on
he parental origin of the gene (Ferguson-Smith, 2011). Some
mprinted genes are expressed from the maternally inherited allele
nly (and repressed on the paternal chromosome), whereas others
re expressed uniquely from the paternal chromosome. More than
undred protein-coding genes are imprinted in humans and mice
Williamson et al., 2013; Morison et al., 2005). These play diverse
oles in development and growth, and contribute to physiology and
ehaviour (Peters, 2014). It has become apparent that hundreds of
egulatory non-coding RNAs (ncRNAs), including microRNAs, snoR-
As and long ncRNAs, are controlled by genomic imprinting as well
Girardot et al., 2012; Pauler et al., 2012). The biological functions of
hese imprinted ncRNAs remain less well understood. This review
ighlights the importance of chromatin and imprinted ncRNAs in
he developmental control of imprinted gene expression.
Imprinted genes are organised in clusters, forming chromo-
omal domains of tens of kilobases to several megabases in size
Kelsey and Feil, 2013). The imprinted expression of the genes
ithin each of these domains is controlled by an ‘imprinting con-
rol region’ (ICR). ICRs are essential regulatory DNA elements, which
re rich in CpG dinucleotides, and are marked by germline-derived
NA methylation on one of the two parental alleles. ICRs are
omparable between each-other in that they all carry parent-of-
rigin speciﬁc DNA methylation, which is maintained throughout
evelopment (Kota and Feil, 2010; Smallwood and Kelsey, 2012).
his somatic maintenance process involves, besides the 5-methyl-
ytosine (5mC) methylation itself, various protein factors and
ovalent histone modiﬁcations (Kacem and Feil, 2009; Kelsey and
eil, 2013). The way the differentially methylated ICRs bring about
he imprinted gene expression at nearby genes differs between
omains. At several domains the imprinted expression is tissue-
peciﬁc (Peters, 2014). The way in which ICRs mediate imprinted
xpression involves covalent chromatin modiﬁcations and higher
rder chromatin structuration. At some imprinted loci, interest-
ngly, the tissue-speciﬁcity is linked to the action of imprinted
ong ncRNAs (lncRNAs). These novel insights are presented and
iscussed below.
. Chromatin and the control of DNA methylation imprints
.1. Acquisition of DNA methylation imprints
The speciﬁcity of the methylation imprints at ICRs is conferred
y their establishment in either the female or the male germline.
he majority of ICRs are methylated on the maternally-inherited
llele, carrying a methylation mark acquired during the ﬁnal stages
f oogenesis. Only three ICRs are ‘paternally methylated’ in mice
nd humans, with the allelic DNA methylation originating from
perm, with imprint acquisition occurring during the fetal stages
f spermatogenesis (Kota and Feil, 2010). Besides the requirement
f the de novo DNA methyltransferase DNMT3A, and that of a non-
atalytically active partner protein, called DNMT3-like (DNMT3L),
mprint acquisition is not fully understood (Kelsey and Feil, 2013;
ota and Feil, 2010). What determines that the DNMT3A/DNMT3L
rotein complex is brought to one set of ICR regions in one germline,
nd to another, in the other germline? Insights into this key ques-
ion have emerged. Transcription through the ICR regions seems
ssential to the process (Chotalia et al., 2009; Henckel et al., 2012).
he modiﬁcation status of the chromatin associated with ICRs is
mportant as well —particularly histone H3 methylation at lysine-
 — and determines whether the de novo methylation machinery
as access or not to its target regions (Ciccone et al., 2009; Henckel
t al., 2012; Ooi et al., 2007). Several recent reviews discuss these
ovel insights into imprint acquisition (Dufﬁe and Bourc’his, 2013;
elsey and Feil, 2013; Kota and Feil, 2010).emistry & Cell Biology 67 (2015) 139–147
2.2. Somatic maintenance of the methylated allele
Here, we  are interested in another determinant of imprinting
speciﬁcity: the somatic maintenance of the differential DNA meth-
ylation status of ICRs. Genome-wide methylation studies have
revealed that more than thousand promoter/CpG island regions
become methylated in either the male or the female germline
(Kobayashi et al., 2012; Smallwood et al., 2011). The differential
methylation is maintained during pre-implantation development
at some of these regions only, and these include all the known ICRs
(Dufﬁe and Bourc’his, 2013; Reik et al., 2001). This exceptional
epigenetic maintenance of ICRs is linked to differential patterns
of histone lysine and arginine methylation between the parental
chromosomes, and several of the responsible histone modifying
enzymes have been identiﬁed (Kelsey and Feil, 2013). Particularly,
chromatin associated with the DNA-methylated alleles of ICRs
is consistently marked by histone H3 lysine-9 trimethylation
(H3K9me3), H3 lysine-64 tri-methylation (H3K64me3), H4 lysine-
20 trimethylation (H4K20me3) and H4 arginine-3 symmetrical
dimethylation (H4R3me2s), and is bound by the heterochromatin
protein-1 gamma  (HP1) (Delaval et al., 2007; Girardot et al.,
2014; Pannetier et al., 2008). To which extent these ‘repressive
chromatin’ features, similar to those at constitutive heterochro-
matin, contribute to the maintenance of the DNA methylation is
not clear. Studies on mouse embryonic stem cells have revealed
minor losses of DNA methylation due to depletion of speciﬁc lysine
methyltransferases (KMTs), including the H3-lysine-9 enzymes
G9a and ESET/SETDB1 (Girardot et al., 2014; Leung et al., 2014;
Quenneville et al., 2011). It is unclear whether these ﬁndings reﬂect
the in vivo situation in the embryo. Absence of G9a in the embryo
does not result in loss of DNA methylation at ICRs (Wagschal et al.,
2008; Xin et al., 2003).
DNMT1 is essential for the embryonic maintenance of the
DNA methylation imprints (Hirasawa et al., 2008). Studies on
imprinting-related diseases in humans (Hirasawa and Feil, 2010)
have pinpointed proteins that contribute to the imprint main-
tenance by DNMT1, particularly in the early embryo (Table 1).
One of these is the KRAB-domain zinc-ﬁnger protein ZFP57 (Li
et al., 2008), a protein which recruits KAP1 (also called TRIM28,
or TIF1B), a platform protein which, in turn, mediates recruitment
of histone modifying enzymes, including the H3-lysine-9 speciﬁc
ESET/SETDB1 (Hirasawa and Feil, 2008). ZFP57 binds to methylated
DNA sequences through recognition of a speciﬁc sequence motif
(‘TGCCGC’), found at many ICRs and at some other differentially
methylated regions (DMRs) as well (Quenneville et al., 2011). In
humans, ZFP57 mutations are associated with ‘transient neonatal
diabetes mellitus’ (TNDM). In these patients, the imprinting disor-
der (ID) is caused by the resulting loss of DNA methylation at the
PLAGL1 gene (Mackay et al., 2008). In some TNDM patients with
heterozygous inactivating ZFP57 mutations, DNA methylation loss
affects other ICRs as well. Mouse studies have conﬁrmed that ZFP57
is essential for embryonic imprint maintenance at multiple ICRs
(Quenneville et al., 2011).
The ﬁrst embryonic cell divisions are critical for imprint mainte-
nance and several maternal (i.e., oocyte derived) proteins have been
shown to be involved. One of these is DPPA3 (also called Stella or
PGC7), a protein present at high levels in oocytes that persists in
the early embryo. This chromatin-associated protein contributes
to the maintenance of DNA methylation on the maternal set of
chromosomes, including at several of the maternal ICRs (Nakamura
et al., 2007). DPPA3 also contributes to the early-embryonic main-
tenance of methylation at two  of the paternal ICRs. DPPA3 protects
against DNA demethylation by inhibiting the conversion of 5mC to
5-hydroxymethyl-cytosine (5hmC) in the zygote (Wossidlo et al.,
2011). How DPPA3 is targeted to speciﬁc loci is not clear, but
this protein recognizes and binds to H3 lysine-9 dimethylation
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Table  1
Factors involved in the maintenance of differential DNA methylation at ICRs.
Factors that are required for somatic maintenance of DNA methylation
Protein Function/characteristic Phenotype due to loss of expression or to knock-down,
in somatic cells/embryos
References
DNMT3A de novo DNA methyltransferase Non-maintenance of methylation imprints due to lack
of de novo methylation
Chen et al. (2003)
DNMT1 Maintenance DNA
methyltransferase
Loss of methylation, loss of imprinted expression at
several genes
Hirasawa et al. (2008)
NLRP2 Cytoplasmic caterpillar family
protein
(somatic?) Loss of methylation at the ICR of the KCNQ1
domain
Meyer et al. (2009)
ZFP57 KRAB domain zinc ﬁnger protein Partial loss of methylation at several ICRs (PLAGL1,
GRB10, and PEG3 loci)
Li et al. (2008), Mackay et al. (2008)
KAP1 KRAB-associated protein 1 Partial loss of methylation at several ICRs (Igf2-H19
and Snrpn loci)
Messerschmidt et al. (2012)
UHRF1 (Np95) Binds to hemimethylated DNA
after replication; recruits DNMT1
Partial loss of methylation at the ICRs of Igf2-H19,
Kcnq1, Dlk1-Dio3 domains
Sharif et al. (2007)
Histones H1 Linker histones Triple knockout (H1c, H1d, H1e): partial loss of
methylation at the ICRs of the Igf2-H19 and Dlk1-Dio3
domains
Yang et al. (2013)
MBD3 Methyl CpG-binding domain
protein-3
partial loss of methylation at the ICR of the Igf2-H19
locus
Reese et al. (2007)
MTA2 Metastasis tumour antigen-2 partial loss of methylation at the ICRs of the Igf2-H19
and Peg3 domains
Ma  et al. (2010)
RBBP1/RBBP1L1 Retinoblastoma (Rb)-binding
proteins
combined knockout: loss of ICR methylation at the
PWS  (Snrpn) domain
Wu et al. (2006)
DPPA3 (PGC7/Stella) Methylated histone (H3K9me2)
binding protein
partial loss of methylation at several ICRs Nakamura et al. (2007)
Factors that prevent de novo DNA methylation
Protein Function/characteristic Phenotype due to loss of expression or to knock-down,
in somatic cells/embryos
References
CTCF Zinc ﬁnger protein involved in
chromatin structuration
Gain of methylation at the ICR of the Igf2-H19 domain Schoenherr et al. (2003)
ZFP42 Zinc ﬁnger protein Gain of methylation at the ICRs of the Peg3 and Gnas
domains
Kim et al. (2011)
OCT4 Pluripotency transcription factor Binding-site mutations induce gain of methylation at
the ICR of the IGF2-H19 locus
Abi Habib et al. (2014),  Hori et al. (2012)
SOX2 Pluripotency transcription factor Binding-site mutations induce gain of DNA
methylation at the ICR of the IGF2-H19 locus
Abi Habib et al. (2014),  Hori et al. (2012)
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H3K9me2), which is present on the DNA-methylated allele of
CRs (Nakamura et al., 2012). Embryonically expressed DPPA3 con-
ributes to imprint maintenance at later developmental stages,
articularly in the pluripotent cells of the early embryo (Xu et al.,
015).
Proteins that contribute to the maintenance of methylation
mprints include the methyl-CpG-binding domain protein MBD3.
BD3 is amongst several proteins that associate speciﬁcally with
he methylated alleles of ICRs. It is part of the ‘nucleosome
emodeling and deacetylase’ (NuRD) complex, which also includes
he metastasis tumour antigen-2 (MTA2) protein. Knock-down of
ither Mbd3 or Mta2 gave partial loss of DNA methylation at the
aternally-methylated ICR of the Igf2-H19 locus in mouse embryos,
ut not at several other analysed ICRs (Ma  et al., 2010; Reese et al.,
007).
Retinoblastoma-binding protein 1 (RBBP1, also called ARID4A)
inds with a moderate afﬁnity to both H3K9me3 and H4K20me3
Gong et al., 2012). This nuclear protein is involved in the con-
rol of gene expression at the imprinted domain associated with
he neuro-behavioural disorder, Prader-Willi Syndrome (PWS).
argeted deletion of Rbbp1 in the mouse, together with that of
he related Rbbp1-like 1 (Rbbp1L1) gene, gave reduced levels of
3K9me3 and H4K20me3, and partial loss of DNA methylation,
t the ICR controlling the PWS  domain (Wu  et al., 2006). These
mportant data highlight that readers of histone-lysine methylation
ontribute to the somatic maintenance of methylation imprints, at
east at the PWS  domain.gainst de novo DNA methylation
pn loci)
Ginno et al. (2012)
2.3. Somatic maintenance of the unmethylated allele
Recent mouse studies highlight the importance to protect the
non-methylated allele of DMRs against the acquisition of de novo
DNA methylation (Proudhon et al., 2012). Different nuclear pro-
teins contribute to this developmental process (Table 1). These
include the zinc-ﬁnger proteins ZFP42 (Kim et al., 2011) and
‘CCCTC-binding factor’ (CTCF). CTCF is an essential architectural
protein involved in the formation of long-range interactions and
chromatin loops. It binds to the unmethylated allele of the Igf2-
H19 ICR (Fig. 1A). Deletion of the ICR’s four CTCF binding sites in
the mouse and hence, abrogation of CTCF binding, led to aber-
rant DNA methylation at the ICR in the early embryo (Engel et al.,
2006; Schoenherr et al., 2003). Interestingly, this ICR also com-
prises binding sites for the transcription factors OCT4 and SOX2.
Mutations of these sites lead to aberrant gains of DNA meth-
ylation and are associated with the foetal overgrowth disorder,
Beckwith-Wiedemann Syndrome (BWS) (Abi Habib et al., 2014).
This ﬁnding indicates that pluripotency-linked transcriptional reg-
ulators protect the unmethylated allele of this ICR against de novo
DNA methylation in the early embryo.
Chromatin associated with the unmethylated alleles of
ICRs is characterized by histone H3 and H4 acetylation at
lysine residues and by enrichment of H3 lysine-4 di- and/or
trimethylation (H3K4me2/H3K4me3) (Delaval et al., 2007). Bio-
chemical studies have shown that H3K4-methylation prevents the
DNMT3A/DNMT3L complex to be bound and active in the context
142 I. Sanli, R. Feil / The International Journal of Biochemistry & Cell Biology 67 (2015) 139–147
Fig. 1. ICR-mediated chromosome looping controls gene expression at imprinted domains. (A) Schematic presentation of the 100-kb IGF2-H19 locus (adapted from Ito et al.,
2013). CTCF and cohesins bind to the ICR on the unmethylated maternal allele. This mediates a chromatin loop which insulates the Igf2 gene from enhancers downstream
of  H19. On the paternal chromosome, a different higher order structuration brings the enhancers to Igf2. This activates Igf2 transcription in mesodermal and endodermal
tissues.  (B) Schematic presentation of the 700-kb Peg13-Kcnk9 domain (adapted from Court et al., 2014), where CTCF binding occurs to the non-methylated allele of the
(putative) ICR only. In neuronal lineages, this mediates differential chromatin looping, which, on the maternal chromosome, brings an enhancer close to Kcnk9.  On the
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eader  is referred to the web version of the article.).
f chromatin, and hence, protects against de novo DNA methylation
Guo et al., 2015; Ooi et al., 2007).
Most ICRs comprise CpG island promoters that are trans-
riptionally active on the unmethylated allele. This most likely
xplains why there is ‘active chromatin’ characterized by
3K4me2/H3K4me3 on the unmethylated allele. A recent study
hows that there is formation of R-loops on the unmethylated
lleles of ICRs (Ginno et al., 2012). These double-stranded RNA-DNA
tructures form on the transcribed DNA strand, most pronouncedly
n embryonic stem cells. In vitro studies suggest that such R-loops
ould protect the unmethylated alleles of ICRs against de novo DNA
ethylation in the early embryo (Ginno et al., 2012).
. Higher order chromatin structuration at imprinted gene
oci
Because of the mono-allelic methylation imprints and associ-
ted chromatin features, the two parental copies of ICRs become
on-equivalent. This functional difference induces the imprinted
xpression in the embryo. The mechanisms through which ICRs
ediate imprinting diverge between domains. One scenario is the
ormation of chromatin loops that include the ICR, and which
epend on the ICR’s methylation status. A well known exam-
le is the Igf2-H19 locus, where, on the unmethylated maternal
llele, the ICR confers a chromatin loop that prevents the distal
gf2 gene to interact with proximally located enhancers (Fig. 1A).
his ‘boundary function’ requires CTCF binding to the ICR, which
riggers recruitment of cohesin proteins. The bound CTCF-cohesin
omplexes induce higher order looping structures on the maternal
hromosome (allowing expression of the H19 gene) that are differ-
nt from those on the paternal chromosome (allowing expression of
gf2) (Kurukuti et al., 2006; Murrell et al., 2004). Despite the ubiqui-
ous expression of CTCF and cohesin proteins, the Igf2 gene does not
isplay paternal allele-speciﬁc expression throughout the embryo.
on-imprinted, biallelic expression occurs in the choroid plexus maternal chromosome and maternally expressed genes, blue depicts the paternal
rinted genes (For interpretation of the colour information in this ﬁgure legend, the
and the leptomeninges of the brain (Feil et al., 1994). Yet-unknown
tissue-speciﬁc factors inﬂuence the ICR’s boundary function and its
effects on gene expression, possibly including factors that activate
enhancers in speciﬁc tissues.
Also at other domains, imprinted gene expression requires chro-
matin looping through CTCF and cohesins (Franco et al., 2014).
One example is an imprinted locus comprising the Peg13 (pater-
nally expressed gene 13) and Kcnk9 genes. Both these genes show
imprinted expression in the brain in mice and humans, with Peg13
expressed from the paternal, and Kcnk9 from the maternal, chro-
mosome. Peg13 comprises the single DMR  of the locus and is
methylated on the maternal chromosome. The non-methylated
paternal copy of this putative ICR is bound by CTCF and cohesins
(Fig. 1B). Chromatin conformation capture (‘3C’) studies have
shown that the CTCF/cohesin binding prevents an enhancer to loop
onto the Kcnk9 gene, which explains the lack of Kcnk9 expression
on the paternal chromosome. On the maternal chromosome, the
DMR is fully methylated and not bound by CTCF, and enhancer-
promoter interactions (activating Kcnk9)  are readily detected by
3C (Court et al., 2014). The CTCF/cohesin-mediated, brain-speciﬁc
imprinting at the Peg13-Kcnk9 domain might be relevant to disease,
since this chromosomal region is linked to an autosomal recessive
mental retardation and dysmorphism syndrome (Court et al., 2014).
At some imprinted loci, chromatin looping depends on
imprinted lncRNAs (Franco et al., 2014). At the imprinted Kcnq1
domain on mouse chromosome 7, for instance, long-range chro-
matin interactions require an lncRNA that is expressed from the
domain’s ICR. This 750-kb domain is controlled by a maternally
methylated, intragenic ICR located within the Kcnq1 gene, one of
the imprinted genes of the domain (Fig. 2A). This ICR represses
multiple genes in cis on the paternal chromosome, including Kcnq1
(Fitzpatrick et al., 2002). This silencing mechanism requires a 90-
kb lncRNA, called Kcnq1ot1, which has its promoter in the ICR.
One way  this maternally expressed lncRNA acts is by mediating
repressive chromatin in cis at genes of the domain (Pandey et al.,
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Fig. 2. Long non-coding RNAs mediate imprinted gene repression. Several imprinted domains comprise genes that are imprinted in extra-embryonic lineages only (Wagschal
and  Feil, 2006). Their allelic repression in the placenta appears independent of DNA methylation, but involves G9a-, PRC1- and PRC2-mediated histone modiﬁcations. (A)
Schematic presentation of the 800-kb mouse Kcnq1 imprinted domain in the placenta. Its intragenic ICR transcribes the lncRNA Kcnq1ot1 on the paternal chromosome. In
the  placenta, this nuclear lncRNA represses proximally and distally located genes. This chromatin repression involves G9a-mediated H3K9-methylation, PRC2-mediated
H3K27me3 and PRC1-mediated H2AK119ub (Terranova et al., 2008; Wagschal et al., 2008). Genes in the central part of the domain (Phlda2, Slc22a18, Cdkn1c and Kcnq1)  are
imprinted in both the embryo and the placenta, and also this depends on Kcnq1ot1 (Pandey et al., 2008). (B) At the 300-kb mouse Igf2r locus, an intragenic ICR transcribes
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ln  lncRNA-called Airn-from its non-methylated paternal allele exclusively. Airn re
nvolves G9a-mediated H3-lysine 9 methylation (Nagano et al., 2008). The Igf2r gen
nterference brought about by Airn transcription (Latos et al., 2012). Colour codes a
008; Terranova et al., 2008; Umlauf et al., 2004), a function further
iscussed below. Recent research indicates that Kcnq1ot1 stabi-
izes long-distance chromatin interactions between the ICR and the
cnq1 gene promoter. This structuration is CTCF-dependent (the
CR comprises two CTCF sites) and is required for the silencing
f Kcnq1 on the maternal chromosome (Zhang et al., 2014). Dur-
ng heart development, interestingly, Kcnq1 becomes re-expressed
rom both the parental chromosomes. This switch from imprinted
o non-imprinted expression correlates with alterations in the
ong-range interactions within the domain detected by the 3 C tech-
ology (Schultz et al., 2015). It remains to be discovered which
eart-lineage speciﬁc factors are involved in this developmental
witch.
. Long non-coding RNAs and chromatin in imprinted gene
epression
Most imprinted domains express at least one lncRNA, transcrip-
ion of which, or the RNA itself, controls close-by genes (Pauler et al.,
012). Recent research indicates that imprinted lncRNAs can affect
ene expression in trans as well (Kaneko et al., 2014; Stelzer et al.,
014). This may  contribute to a reported cross-talk between, and
o-regulation of, imprinted genes (Al Adhami et al., 2015; Cattanach
t al., 2004; Varrault et al., 2006).
.1. Chromatin repression in cis
Similarly as the Kcnq1 domain, the Igf2-receptor (Igf2r) locus
s controlled by a maternally methylated ICR, located in the sec-
nd intron of the Igf2r gene (Fig. 2B). This intragenic ICR comprises
he promoter of a 118-kb lncRNA expressed from the paternal
llele, antisense to Igf2r (Latos et al., 2012; Pauler et al., 2012). Ele-
ant studies in the mouse have shown that transcription of this
ncRNA, called Airn, is required for the repression of Igf2r on thes in cis two  genes in the placenta, Slc22a2 and Slc22a3. This chromatin repression
printed in both the embryo and the placenta, most likely through transcriptional
n Fig. 1.
paternal chromosome, and that of two cation-transporter genes
within the domain (Slc22a2, Slc22a3), which are both imprinted in
the extra-embryonic lineages only (Sleutels et al., 2002). Similar
studies, preventing transcription of a full-length lncRNA through
insertion of a premature poly-adenylation signal, have been per-
formed on the Kcnq1 domain (Pandey et al., 2008). They established
that also Kcnq1ot1 lncRNA mediates gene repression in cis (Pandey
et al., 2008). Interestingly, several of the Kcnq1ot1-controlled genes
are imprinted in the extra-embryonic lineages only (Umlauf et al.,
2004); which provides another parallel with the imprinted Igf2r
locus.
How do lncRNAs exert their repressive effects onto the genes
of their imprinted domains? This has been technically challenging
to explore, and it is often difﬁcult to distinguish between effects
related to lncRNA transcription, and direct effects of the lncRNAs
themselves (Bassett et al., 2014; Pauler et al., 2012). Nevertheless,
the current data indicate that Kcnq1ot1 and Airn are both involved
in chromatin repression in cis.  Studies in the placenta have pro-
vided evidence that this mechanism involves repressive histone
lysine methylation and ubiquitination (Lewis et al., 2004; Nagano
et al., 2008; Pandey et al., 2008; Terranova et al., 2008; Umlauf
et al., 2004). In the embryo proper, transcription of Airn is impor-
tant for bringing about repression at the promoter of the host
Igf2r gene. Extensive gene targeting and molecular studies (Latos
et al., 2012) indicate that this occurs through a transcriptional
interference mechanism, rather than involving the Airn lncRNA
itself.
4.2. Histone methylation controls placenta-speciﬁc imprintingThe placental genes controlled by Kcnq1ot1 are located in
the proximal and distal portions of the Kcnq1 domain (Fig. 2A).
Their allelic silencing in the mouse placenta is associated with
H3 lysine-27 trimethylation (H3K27me3), H3K9me2 and H2A
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ysine-119 mono-ubiquitination (H2AK119ub) (Terranova et al.,
008; Umlauf et al., 2004). This combination of repressive mod-
ﬁcations marks the distal and proximal parts of the imprinted
omain in the placenta. The promoters of the imprinted placental
enes remain unmethylated, and maintenance of this chromatin-
ediated repression is not dependent on DNA methylation (Lewis
t al., 2004; Sleutels et al., 2002; Tanaka et al., 1999). The repres-
ive H2AK119ub and H3K27me3 are controlled by the Polycomb
roup proteins RING1B (Polycomb Repressive Complex 1, PRC1)
nd EZH2 (PRC2 complex), respectively. Similarly as observed at
ox genes in embryonic cells (Eskeland et al., 2010), the RING1B-
ediated H2AK119ub at the Kcnq1 domain induces chromatin
ompaction measurable by DNA ﬂuorescence in situ hybridization
FISH) (Terranova et al., 2008).
The repressive H3K9me2 at the Kcnq1 domain is controlled by
9a (Wagschal et al., 2008). Also the recruitment of this lysine
ethyltransferase (KMT) to the placental genes depends on the
xpression of the full-length Kcnq1ot1 ncRNA (Pandey et al., 2008).
NA/DNA FISH studies have shown that Kcnq1ot1 lncRNA co-
ocalises with the placental genes which it controls, in placental
ells, but not in embryonic cells (Redrup et al., 2009). How Kcnq1ot1
ediates the recruitment and/or the activity of PRC1 and PRC2
omplexes, and that of G9a, onto speciﬁc target genes is not under-
tood. This is a tissue-speciﬁc process, despite the ubiquitous
xpression of the Kcnq1ot1 lncRNA itself. Recent biochemical stud-
es suggest that EZH2, the PRC2 catalytic protein that tri-methylates
3-lysine-27, interacts with Kcnq1ot1 and other lncRNAs (Kaneko
t al., 2014; Zhao et al., 2010). Whether lncRNA-protein interactions
uide PRCs to the placental target genes, or whether they alter the
ctivity of already-bound PRC complexes, is not known.
G9a also contributes to the allelic repression of Slc22a3, one
f the placental imprinted genes of the Igf2r domain (Fig. 2B).
irn lncRNA is required for the recruitment of G9a to the Slc22a3
romoter in mid-gestation placenta, which brings about the repres-
ive H3K9 methylation (Nagano et al., 2008; Sleutels et al.,
002). Biotin-based biochemical labeling and puriﬁcation stud-
es show that Airn physically associates with Slc22a3, hundreds
f kilobases away from the Airn transcription unit (Nagano
t al., 2008). Again here, the precise targeting mechanism(s)
nd what determines its strict tissue-speciﬁcity, remain to be
iscovered.
A third domain with G9a and PRC-dependent placenta-speciﬁc
mprinting is the Peg10/Sgce locus on mouse chromosome 6 (Monk
t al., 2008), but it is yet unknown whether there is involvement
f an lncRNA here as well. Targeting studies in the mouse conﬁrm
hat repressive histone methylation contributes indeed to placental
mprinting. In G9a-deﬁcient placentae, there is a partial relax-
tion of imprinting at placental genes (Ascl2, Cd81, Obpl5)  of the
cnq1 domain, at Slc22a3 gene of the Igf2r domain, and at Tfpi2
f the Peg10/Sgce locus. The extent of ‘loss of imprinting’ varies
etween G9a-deﬁcient placentae (Wagschal et al., 2008), indicating
hat H3K9me2 is not the only repressive ‘layer’ involved. In EED-
eﬁcient mouse conceptuses, which lack the PRC2 complex, partial
oss of imprinting has been reported for Ascl2 at the Kcnq1 domain
Mager et al., 2003) and for the Tfpi2 gene at the Peg10/Sgce locus
Monk et al., 2008).
It remains to be discovered which tissue-speciﬁc factors deter-
ine the speciﬁcity of the placental imprinting. To start addressing
his question, different groups have explored whether the phe-
omenon is evolutionarily conserved in humans. Similarly as in
odents, there is maternal allele-speciﬁc expression of the TFPI2
ene at the PEG10/SGCE domain in human placenta (Monk et al.,
008). There is also imprinted expression of the SLC22A2 and
LC22A3 genes at the IGF2R locus in early human placenta, albeit in
 polymorphic manner (only some of the analysed placentae dis-
layed imprinted expression) (Monk et al., 2006). Contrary to theemistry & Cell Biology 67 (2015) 139–147
mouse, the ASCL2, CD81, OSBPL5 and NAP1L4 genes of the KCNQ1
imprinted domain are expressed biallelically in human placenta
(Monk et al., 2006). These data may  imply that speciﬁc factors
involved in the placental imprinting in rodents are missing in
human placenta.
4.3. Repressive trans effects on other imprinted loci
Imprinted lncRNAs may  exert repressive effects in trans as
well, onto imprinted genes located elsewhere in the genome.
Such effects were reported for an lncRNA at the imprinted PWS
domain, called IPW, which is transcribed from the paternal chro-
mosome (Stelzer et al., 2014). In human iPS cells in which this
imprinted lncRNA was  repressed by knock-down, there was  a
marked up-regulation of the maternal genes of the DLK1-DIO3
domain on human chromosome 14. Over-expression of IPW gave
rise to reduced expression of the maternal genes of the DLK1-
DIO3 domain. Though not involving altered ICR methylation at
the DLK1-DIO3 domain, the precise mechanism through which
this lncRNA acts is yet unknown. Nevertheless, conceptually this
is an important discovery, since it emphasizes that mammalian
imprinted genes are interdependent and co-regulated in part, and
thereby constitute an ‘imprinted gene network’ (Al Adhami et al.,
2015).
One of the maternal allele-speciﬁc RNAs of the Dlk1-Dio3
imprinted domain is an lncRNA, called Gtl2 (also named Meg3)
(Fig. 3A). This lncRNA is nuclear, interacts in vitro with the EZH2
protein of the PRC2 complex and physically associates with the
Dlk1-Dio3 domain in mouse embryonic cells (Kaneko et al., 2014;
Kota et al., 2014; Zhao et al., 2010). This lncRNA could thus be
involved in gene repression in cis,  and possibly also in trans (Kaneko
et al., 2014).
5. Non-coding RNAs in imprinted gene activation during
development
Some mammalian lncRNAs are known to bring about ‘active’
chromatin through recruitment of (Trithorax) protein complexes
that mediate H3K4 methylation and gene transcription (Orom et al.,
2010). These include Hottip,  an lncRNA involved in the develop-
mental activation of the Hoxa cluster of homeotic genes (Wang
et al., 2011), and an lncRNA that activates gene expression at the
FSHD (Facioscapulohumeral dystrophy) disease locus in humans
(Cabianca et al., 2012). This recent insight has raised the possibility
that imprinted ncRNAs might be involved in developmental gene
activation as well.
Mouse targeting studies on the Dlk1-Dio3 domain (Fig. 3A)
have shown that its paternally methylated ICR activates imprinted
gene expression on the maternal chromosome. The maternal ICR
allele activates all the maternal ncRNAs of the locus, including Gtl2
lncRNA. This enhancer-like action is linked to RNA polymerase-II
recruitment to the ICR, and to bidirectional transcription of multi-
ple ncRNAs that are relatively short and non-poly-adenylated (Kota
et al., 2014). The ICR ncRNAs, as well as local histone modiﬁcations,
are reminiscent to what has been reported for active enhancers
(Natoli and Andrau, 2012). How the transcription of ICR ‘enhancer
RNAs’, or these ncRNAs themselves, is involved in the activation of
gene transcription is not known. In embryonic stem and iPS cells,
however, their expression correlates with an early timing of DNA
replication in S phase, and with a more central sub-nuclear local-
ization of the locus compared to that on the paternal chromosome
(Kota et al., 2014).
A second ICR which activates genes in cis is found at the PWS
imprinted domain (also called the Snrpn domain) on mouse chro-
mosome 7 (human chromosome15q11-13). This 2-Mb domain
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Fig. 3. ICR-mediated activation at imprinted genes during development. (A) At the 1-Mb Dlk1-Dio3 domain, an intergenic ICR is essential to activate different ncRNA genes
on  the maternal chromosome in the early embryo, including the lncRNA Gtl2. This enhancer-like function is associated with ncRNA expression and RNA-PolII recruitment at
the  ICR (Kota et al., 2014). The nuclear lncRNA Gtl2 accumulates at the locus and could play a role in the tissue-speciﬁc gene repression of the Dlk1 gene at the domain. (B)
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fhe  2-Mb PWS  imprinted domain has an intragenic ICR (in the Snrpn gene) which is
hromosome, particularly in the brain (Bielinska et al., 2000). The activation of distan
Rabinovitz et al., 2012). Colour codes and symbols are as in Fig. 1.
omprises multiple genes that are activated on the paternal chro-
osome during neurogenesis (Lee and Bartolomei, 2013; Peters,
014). It is the unmethylated paternal copy of the ICR that controls
his activation, which occurs at one side of the domain at more
han 1.5 Mb  from the ICR. This enhancer-like function involves
hromosome looping bringing the ICR in close proximity to the
istant target genes (Rabinovitz et al., 2012). The non-methylated
aternal copy of the ICR also drives the expression of an lncRNA,
alled Snurf/Snrpn, but it is unknown whether this is required for
ong-distance chromatin interactions (Figure 3B).
. Clinical relevance of perturbed chromatin mechanisms
A growing number of congenital diseases are known to be
aused by perturbation of imprinting (Hirasawa and Feil, 2010). In
ome of these imprinting disorders (IDs), the causal mechanisms
re genetic in most patients, involving deletions, translocations
r other chromosomal abnormalities at the imprinted domains
oncerned. Other IDs seem mostly epigenetic in origin, with no
pparent genetic mutations in the patients. In such cases of ‘epige-
etic disease’, there is abnormal maintenance of epigenetic states,
uch that single or multiple ICRs acquire abnormal DNA methyla-
ion. These pathological changes in ICR methylation seem to arise
arly in gestation, probably during pre-implantation development.
imilarly as in mouse embryos (Khosla et al., 2001), once an ICR
ains aberrant DNA methylation, or loses its methylation imprint,
hese alterations persist during subsequent development and affect
mprinted gene expression and phenotype. IDs are reviewed in
etail elsewhere (Hirasawa and Feil, 2010; Horsthemke, 2014;
eters, 2014). We  therefore present a few selected examples only.
Silver-Russell Syndrome (SRS) is an intra-uterine and post-natal
isorder of growth deﬁciency, facial dysmorphism, body asymme-
ry and feeding difﬁculties. It is an infrequent, mostly sporadic,
isease that in ∼70% of patients is caused by embryonic loss of
NA methylation at the ICR of the IGF2-H19 locus. Because of the
TCF-mediated boundary function of this ICR (Fig. 1A), this meth-
lation loss leads to loss of expression of IGF2, a main regulator of
oetal growth.ylated on the maternal chromosome. This ICR activates genes in cis on the maternal
al genes (including Magel2 and Ndn) involves ICR-mediated long-range interactions
Other imprinted domains are suspected to be implicated in
SRS as well. One recent study has reported several patients with
an SRS-compatible clinical phenotype, but with unaltered DNA
methylation at the IGF2-H19 locus. In these patients, there was
a complete loss of DNA methylation at the ICR controlling the
imprinted DLK1-DIO3 domain on human chromosome 14q32.2
(Kagami et al., 2014). Earlier studies had linked maternal uni-
parental disomy (UPD) of chromosome 14q32.2 to a clinically
overlapping ID, called Temple Syndrome (TS) (Ioannides et al.,
2014). It is unknown whether the observed methylation losses at
the two  different ICRs could have a common cause, and to which
extent the IGF2-H19 and DLK1-DIO3 domains are regulatorily and
functionally overlapping.
Beckwith-Wiedemann Syndrome (BWS) is characterized by
foetal and perinatal overgrowth and an increased risk of child-
hood cancers, including Wilms’ tumour (Hirasawa and Feil, 2010).
In about ten percent of affected children, there is the exact oppo-
site epigenetic change as typically observed in SRS: gain of aberrant
DNA methylation at the ICR of the IGF2-H19 locus, leading to
enhanced IGF2 expression. In most BWS  patients, however, there
is loss of DNA methylation at the intragenic ICR controlling the
imprinted KCNQ1 domain. This leads to biallelic expression of the
lncRNA KCNQ1OT1 and, hence, gene repression in cis on both the
parental chromosomes. The gene of which the loss of expression
causes BWS  is the cell cycle gene CDKN1C (Hirasawa and Feil, 2010),
located in the central portion of the KCNQ1 domain (Fig. 2A).
Since perturbation of methylation at individual or multiple ICRs
is causally involved in SRS, BWS, TS and other IDs of aberrant
growth, physiology or behaviour, it will be important to identify
and explore additional factors that might be involved.
7. Conclusions and future directions
Considerable progress has been made during the last years.
Novel insights have emerged, particularly into the somatic main-
tenance of the differential DNA methylation status of ICRs.
These improved our understanding of IDs in humans. In fact,
it has been through clinical genetic studies that several of the
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on-histone proteins involved were discovered, and could be tested
n animal studies subsequently. Above, we also reviewed the
mportance of chromatin features and regulatory ncRNAs in the
issue-speciﬁcity of imprinted gene expression. At several domains
epressive histone methylation is mediated by PRC complexes
nd KMTs, and at some domains, there is involvement of lncR-
As in the recruitment/activity of chromatin regulatory complexes
s well. We  now understand better how chromatin repression,
ong-range looping and regulatory lncRNAs contribute to imprinted
xpression. Long-range interactions can now be studied genome-
ide using high-throughput 3 C technologies. Such approaches,
ombined with efﬁcient technologies to target key elements (e.g.,
TCF binding sites), will undoubtedly provide new insights into
he developmental structuration of imprinted domains. Mecha-
istic similarities between different domains have emerged as
ell, particularly as concerns placental imprinting. A lot is still to
e discovered about which factors deﬁne the tissue-speciﬁcity of
mprinting. One might expect transcription factors to play roles in
uiding chromatin conﬁguration and gene expression. The recent
tudies on the PWS  and DLK1-DIO3 imprinted domains emphasize
hat factors that control enhancer activity are likely to be involved
s well. Given the rapidly growing interest in this ﬁeld, undoubt-
dly, novel regulatory factors and mechanisms will emerge during
he years to come.
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